Scale Up

Dec 02, 2018
Pharmaceutical Technology
Once described as “throwing processes over the wall,” tech transfer is evolving into close collaboration and communication, as potential problems are considered sooner, and new technology is applied. Joseph Szczesiul, director of technical services for UPM Pharmaceuticals, shares best practices.
Dec 02, 2018
Pharmaceutical Technology
Boehringer Ingelheim plans to develop and test new strategies at its Solids Launch facility.
Nov 27, 2018
By Pharmaceutical Technology Editors
The new center will integrate biologics drug discovery, development, clinical manufacturing, and commercial manufacturing.
Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Aug 24, 2018
By Pharmaceutical Technology Editors
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Jul 19, 2018
By Pharmaceutical Technology Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jun 07, 2018
By Pharmaceutical Technology Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
May 30, 2018
By Pharmaceutical Technology Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
Apr 17, 2018
By Pharmaceutical Technology Editors
The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.
Jan 19, 2018
By Pharmaceutical Technology Editors
GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.
native1_300x100
lorem ipsum